Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes

Background: Lung adenocarcinoma (LUAD) is the most common variant of non–small cell lung cancer (NSCLC) across the world. Recently, the rapid development of immunotherapy has brought a new dawn for LUAD patients. Closely related to the tumor immune microenvironment and immune cell functions, more an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Linbin, Wu, Jiyue, Ge, Jiashu, Li, Xin, You, Bin, Wang, Wei, Hu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206047/
https://www.ncbi.nlm.nih.gov/pubmed/37234773
http://dx.doi.org/10.3389/fcell.2023.1060086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206047/
https://www.ncbi.nlm.nih.gov/pubmed/37234773
http://dx.doi.org/10.3389/fcell.2023.1060086

Ejemplares similares